相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Congenital melanocytic nevi
Danna Moustafa et al.
CURRENT OPINION IN PEDIATRICS (2020)
Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion
Christopher R. McEvoy et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Malignant melanoma with areas of rhabdomyosarcomatous differentiation arising in a giant congenital nevus with RAF1 gene fusion
Aline Baltres et al.
PIGMENT CELL & MELANOMA RESEARCH (2019)
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses
Thomas Botton et al.
CELL REPORTS (2019)
Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations
Vanessa Martins da Silva et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Targeted Genomic Profiling of Acral Melanoma
Iwei Yeh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression
Jieping Hu et al.
BRITISH JOURNAL OF CANCER (2018)
Kinase gene fusions in defined subsets of melanoma
Jacqueline Turner et al.
PIGMENT CELL & MELANOMA RESEARCH (2017)
Analysis of acquired mutations in transgenes arising in Ba/F3 transformation assays: findings and recommendations
Kevin Watanabe-Smith et al.
ONCOTARGET (2017)
Melanoma in congenital melanocytic naevi
V. A. Kinsler et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Discovering and understanding oncogenic gene fusions through data intensive computational approaches
Natasha S. Latysheva et al.
NUCLEIC ACIDS RESEARCH (2016)
CRAF R391W is a melanoma driver oncogene
Mohammad Atefi et al.
SCIENTIFIC REPORTS (2016)
Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis
Claudia M. Salgado et al.
MELANOMA RESEARCH (2015)
TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia
Nan Wang et al.
ONCOTARGET (2015)
Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1
Xin-Hong Pei et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
NRAS Mutation Is the Sole Recurrent Somatic Mutation in Large Congenital Melanocytic Nevi
Christelle Charbel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
Thomas Wiesner et al.
NATURE COMMUNICATIONS (2014)
Multiple Congenital Melanocytic Nevi and Neurocutaneous Melanosis Are Caused by Postzygotic Mutations in Codon 61 of NRAS
Veronica A. Kinsler et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Sox 10 promotes the formation and maintenance of giant congenital naevi and melanoma
Olga Shakhova et al.
NATURE CELL BIOLOGY (2012)
The SoxD transcription factors-Sox5, Sox6, and Sox13-are key cell fate modulators
Veronique Lefebvre
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Genotypic and Gene Expression Studies in Congenital Melanocytic Nevi: Insight into Initial Steps of Melanotumorigenesis
Barbara Dessars et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma
D. T. W. Jones et al.
ONCOGENE (2009)
The MAPK pathway in melanoma
Leslie A. Fecher et al.
CURRENT OPINION IN ONCOLOGY (2008)
Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations
Juergen Bauer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Ba/F3 cells and their use in kinase drug discovery
Markus Warmuth et al.
CURRENT OPINION IN ONCOLOGY (2007)
High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi
Nami Ichii-Nakato et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)